Brief: Oxford Nanopore Technologies Says Trial Set For 2027 To Adjudicate MGI Australia's Defenses
Feb 27 (Reuters) - Oxford Nanopore Technologies PLC ONT.L: OXFORD NANOPORE TECH - UPDATE ON LEGAL ACTION AGAINST MGI AUSTRALIA OXFORD NANOPORE TECHNOLOGIES PLC - TRIAL SET FOR 2027 TO ADJUDICATE MGI'S DEFENSES OXFORD NANOPORE TECHNOLOGIES PLC - MGI CONCEDES INFRINGEMENT OF FOUR OXFORD NANOPORE PATENTS OXFORD NANOPORE- ISSUED PROCEEDINGS IN UK ALLEGING TRADE SECRETS INFRINGEMENT, BREACH OF CONFIDENCE, BREACH OF CONTRACT AGAINST MANY MGI/ BGI ENTITIES Source text: ID:nRSa7750Ua Further company coverage: ONT.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oxford Nanopore Technologies
See all newsBrief: Oxford Nanopore Technologies Says Nick Keher, CFO, To Assume Additional Responsibilities From July 1, 2026
Oxford Nanopore Tech - Changes to Director Roles and Responsibilities
UK's IP Group rebuffs top investor Railpen's $810 million takeover proposal
Brief: Railways Pension Trustee Company Limited Announces Possible Offer For All IP Group Shares
Oxford Nanopore Tech - Share Incentive Plan - Director/PDMR Shareholding